SCHEMBL17849247

SCHEMBL17849247

N=C(c1ccc(N2CCOCC2)cc1)c1c(Nc2c(F)cc(F)cc2F)cc[nH]c1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.41
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 3/20 0.41
TDP1 Q9NUW8 3/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
GAA P10253 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
EGFR P00533 5/20 0.38
ZAP70 P43403 5/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
ALOX15 P16050 1/20 0.37
ALOX12 P18054 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.36
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17849188 0.91 EGFR (0.40) MAPTALDH1A1NPC1RAB9AEGFR
SCHEMBL17849227 0.91 TYK2 (0.42) EGFRZAP70HDAC3HDAC4HDAC1
SCHEMBL17849222 0.90 ALDH1A1 (0.36) MAPTALDH1A1KDM4ETDP1NPC1
SCHEMBL17849244 0.83 TYK2 (0.40) ALDH1A1KDM4EEGFRZAP70HDAC3
SCHEMBL17849249 0.81 EGFR (0.40) ALDH1A1EGFRMAOB
SCHEMBL17849223 0.81 MAPT (0.41) MAPTALDH1A1KDM4ENPC1RAB9A
SCHEMBL16623493 0.79 TYK2 (0.39)
SCHEMBL16623509 0.79 NPC1 (0.46) MAPTALDH1A1KDM4ENPC1RAB9A
SCHEMBL17849216 0.79 AR (0.33) NPC1RAB9AEGFRZAP70
SCHEMBL17849225 0.77 PDCD1 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9371320-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-21 US disclosed
US-9371320-B2 Heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-06-21 US disclosed